Rose, A. A. N., Annis, M. G., Frederick, D. T., Biondini, M., Dong, Z., Kwong, L., . . . Siegel, P. M. (2016). MAPK Pathway Inhibitors Sensitize BRAF Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB. Clin Cancer Res.
Chicago Style CitationRose, April A. N., et al. "MAPK Pathway Inhibitors Sensitize BRAF Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB." Clin Cancer Res 2016.
MLA CitationRose, April A. N., et al. "MAPK Pathway Inhibitors Sensitize BRAF Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB." Clin Cancer Res 2016.
Warning: These citations may not always be 100% accurate.